Talking Synthetic Biology — Launch of Synthetic Biology Dialogue Report
Venter does it again — Landmark paper published by the J. Craig Venter Institute
Redesigning ribosomes — Nature paper by the Chin lab
3 April 2009
The safety of early applications of synthetic biology may be adequately addressed by the existing regulatory framework for biotechnology, especially in contained laboratories and manufacturing facilities. But further advances in this emerging field are likely to create significant challenges for U.S. government oversight, according to a new report, authored by Michael Rodemeyer of the University of Virginia. Synthetic biology promises major advances in areas such as biofuels, specialty chemicals, and agriculture and drug products.
In "New Life, Old Bottles: Regulating First-Generation Products of Synthetic Biology", Rodemeyer examines the benefits and drawbacks of using the existing U.S. regulatory framework for biotechnology to cover the new products and processes enabled by synthetic biology.
